|
| 36983106 | Cardiovascular Risk Factor Control in 70- to 95-Year-Old Individuals: Cross-Sectional Results from the Population-Based AugUR Study. | J Clin Med | 2023 |
| 37657634 | Use of Analog and Human Insulin in a European Hemodialysis Cohort With Type 2 Diabetes: Associations With Mortality, Hospitalization, MACE, and Hypoglycemia. | | 2023 |
| 37915964 | Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study. | Kidney Med | 2023 |
| 37735349 | KidneyGPS: a user-friendly web application to help prioritize kidney function genes and variants based on evidence from genome-wide association studies. | BMC Bioinformatics | 2023 |
| 38003595 | Systemic Evidence for Mitochondrial Dysfunction in Age-Related Macular Degeneration as Revealed by mtDNA Copy Number Measurements in Peripheral Blood. | Int J Mol Sci | 2023 |
| 37989062 | Meta-GWAS on PCSK9 concentrations reveals associations of novel loci outside the PCSK9 locus in White populations. | Atherosclerosis | 2023 |
| 37787795 | Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. | JAMA | 2023 |
| 37417318 | Filling the gap: Genetic risk assessment in hypercholesterolemia using LDL-C and LPA genetic scores. | | 2023 |
| 37034649 | Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications. | medRxiv | 2023 |
| 37406784 | Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor. | | 2023 |
| 37277652 | Genetic studies of paired metabolomes reveal enzymatic and transport processes at the interface of plasma and urine. | Nat Genet | 2023 |
| 37337107 | Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. | Nat Genet | 2023 |
| 36644921 | Commutability Assessment of Candidate Reference Materials for Lipoprotein(a) by Comparison of a MS-based Candidate Reference Measurement Procedure with Immunoassays. | | 2023 |
| 36644914 | Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests. | | 2023 |
| 36959271 | A polygenic and family risk score are both independently associated with risk of type 2 diabetes in a population-based study. | Sci Rep | 2023 |
| 37070190 | Haplogrep 3 - an interactive haplogroup classification and analysis platform. | | 2023 |
| 36481179 | A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease. | Kidney Int | 2023 |
| 37188555 | Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society. | Atherosclerosis | 2023 |
| 36691956 | Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study. | Eur Heart J | 2023 |
| 35133173 | Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk. | Circ Genom Precis Med | 2022 |
| 36251423 | Consensus and guidelines on lipoprotein(a) - seeing the forest through the trees. | Curr Opin Lipidol | 2022 |
| 36309064 | The kringle IV type 2 domain variant 4925G>A causes the elusive association signal of the LPA pentanucleotide repeat. | J Lipid Res | 2022 |
| 35387881 | PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function. | Clin J Am Soc Nephrol | 2022 |
| 36036785 | Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. | Eur Heart J | 2022 |
| 35961208 | Long-term tracking and population characteristics of lipoprotein (a) in the Cardiovascular Risk in Young Finns Study. | Atherosclerosis | 2022 |
| 35446786 | Genome-wide studies reveal factors associated with circulating uromodulin and its relationships to complex diseases. | JCI Insight | 2022 |
| 35387493 | A Family and a Genome-Wide Polygenic Risk Score Are Independently Associated With Stroke in a Population-Based Study. | Stroke | 2022 |
| 35697829 | Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals. | Commun Biol | 2022 |
| 35644760 | The spoils of war and the long-term spoiling of health conditions of entire nations. | Atherosclerosis | 2022 |
| 35888152 | Association between Usual Dietary Intake of Food Groups and DNA Methylation and Effect Modification by Metabotype in the KORA FF4 Cohort. | Life (Basel) | 2022 |
| 35636145 | Association between a polygenic and family risk score on the prevalence and incidence of myocardial infarction in the KORA-F3 study. | Atherosclerosis | 2022 |
| 35551307 | Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. | Nat Genet | 2022 |
| 35612837 | Relative Telomere Length Is Associated With Age-Related Macular Degeneration in Women. | Invest Ophthalmol Vis Sci | 2022 |
| 35606073 | Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene. | Atherosclerosis | 2022 |
| 35606072 | Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill? | Atherosclerosis | 2022 |
| 35606069 | The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target. | Atherosclerosis | 2022 |
| 35979826 | Lipoprotein(a) and aortic valve stenosis: work in progress. | European Heart Journal | 2022 |
| 36424295 | Studies on lipoprotein(a) and outcomes in peripheral arterial disease: One must not compare apples with pears. | Atherosclerosis | 2022 |
| 35777832 | Mitochondrial DNA and Kidney Function. | Clinical journal of the American Society of Nephrology : CJASN | 2022 |
| 35534298 | The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A. | Atherosclerosis | 2022 |
| 36456248 | Lipoprotein(a) and cardiovascular disease: Make use of the knowledge we have. | Atherosclerosis | 2022 |
| 34298143 | A Predictive Model for Progression of CKD to Kidney Failure Based on Routine Laboratory Tests. | Am J Kidney Dis | 2022 |
| 34096654 | Lipoprotein(a) and SARS-CoV-2 infections: Susceptibility to infections, ischemic heart disease and thromboembolic events. | Journal of Internal Medicine | 2022 |
| 33878186 | Cis-epistasis at the LPA locus and risk of cardiovascular diseases. | Cardiovasc Res | 2022 |
| 34196811 | Lipoprotein(a). | Handbook of Experimental Pharmacology | 2022 |
| 34689037 | Residential greenness-related DNA methylation changes. | Environment international | 2022 |
| 34914850 | Apolipoprotein A-IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study. | J Intern Med | 2022 |
| 35288215 | Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort Study. | Am J Kidney Dis | 2022 |
| 34718514 | Measuring lipoprotein(a): do it without ifs and buts. | European Journal of Preventive Cardiology | 2022 |
| 34887389 | Epigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus. | Nat Commun | 2021 |